Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

March 2018

Powerful Forces Are Reshaping Lab, Pathology

Commentary and Opinion by R. Lewis Dark / R. Lewis Dark

THERE IS NO BETTER WAY TO UNDERSTAND HOW THINGS ARE CHANGING within the house of laboratory medicine than to survey current news. Understanding why and how breaking news stories are indicators of deeply-rooted and forceful trends is essential for lab administrators and pathologists who want to keep their labs positioned to offer sophisticated and financially-sustainable […]

To access this post, you must purchase The Dark Report.

Powerful Forces Are Reshaping Lab, Pathology Read More »

SEC Charges Theranos with ‘Massive Fraud’

Clinical Laboratory / Joseph Burns

CEO SUMMARY: In an action against Theranos and two of its executives, the SEC said in a federal court filing this month that the company, CEO Elizabeth Holmes, and former COO Ramesh “Sunny” Balwani deceived investors into believing that the company’s portable blood analyzer could conduct comprehensive blood tests from drops of blood collected via

To access this post, you must purchase The Dark Report.

SEC Charges Theranos with ‘Massive Fraud’ Read More »

Facing Lawsuit Filed by Humana, Ameritox Closes Lab, Sells Assets

Laboratory Management / Joseph Burns

IN MAY, THE LONG-STRUGGLING Ameritox, LLC, is scheduled to close its laboratory in Greensboro, N.C., according to reporting in the Triad Business Journal. Early this month, the drug-monitoring and urine-analysis company filed a notice with the North Carolina Department of Commerce that it would close the lab and lay off 113 workers. Also, the company

To access this post, you must purchase The Dark Report.

Facing Lawsuit Filed by Humana, Ameritox Closes Lab, Sells Assets Read More »

FDA’s Gottlieb Favors Flexibility with LDTs, NGS

Laboratory Compliance / Joseph Burns

CEO SUMMARY: FDA Commissioner Scott Gottlieb said the FDA wants to reduce the regulatory burden on developers of next-generation sequencing (NGS) and laboratory-developed tests (LTDs). He also wants to give the FDA more flexibility in how it conducts clinical analysis and validation. To do so, the agency would work with third parties, such as the

To access this post, you must purchase The Dark Report.

FDA’s Gottlieb Favors Flexibility with LDTs, NGS Read More »

Why Pharma, Private Equity Want to Reshape Lab Industry

Clinical Laboratory / Joseph Burns

CEO SUMMARY: A disruptive force that involves precision medicine, pharmaceutical companies, and venture capital investors is poised to reshape the clinical laboratory industry. Genetic knowledge makes it possible to match cancer drugs to specific mutations. Pharma companies and professional investors recognize that control of diagnostic technologies and companion diagnostic tests enable them to gain better access

To access this post, you must purchase The Dark Report.

Why Pharma, Private Equity Want to Reshape Lab Industry Read More »

D.C. Circuit Court Reverses Medical Necessity Ruling

Laboratory Management / Joseph Burns

MANY LAB EXECUTIVES were concerned last year after a judge in the District of Columbia Circuit Court ruled that clinical laboratories need to determine that all lab test services physicians order are medically necessary. The court also ruled that ordering physicians do not need to determine medical necessity, noted the law firm McDonald Hopkins in

To access this post, you must purchase The Dark Report.

D.C. Circuit Court Reverses Medical Necessity Ruling Read More »

March 26, 2018 Intelligence: Late Breaking Lab News

Late Breaking Lab News / Robert Michel

On March 6, one of the lab industry’s long-serving executives and consultants, Jack Mattice, PhD, of Vancouver, Wash., died from flu complications. He was 77 years old. Mattice earned a PhD in medical microbiology from University of Oregon. Within a few years, he was handling market development for United Medical Laboratories (UML), of Portland, Ore. UML reached

To access this post, you must purchase The Dark Report.

March 26, 2018 Intelligence: Late Breaking Lab News Read More »

A coming transformation: Control over important diagnostic technologies is about to change hands

TDR Insider / Mary Van Doren

This is an excerpt from a 2,920-word article in the March 26, 2018, issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: Here’s the first look for the lab industry at an

To access this post, you must purchase The Dark Report.

A coming transformation: Control over important diagnostic technologies is about to change hands Read More »

Two Major, Disruptive Changes Coming to Labs

Commentary and Opinion by R. Lewis Dark / R. Lewis Dark

TWO MAJOR, DISRUPTIVE CHANGES lie ahead for both clinical laboratories and anatomic pathology group practices. Each disruptive factor has nothing to do with how payers select in-network labs or reimburse for lab testing services. Rather, one of these two major changes involves fundamental advances in the diagnostic technologies used by labs to diagnose disease and

To access this post, you must purchase The Dark Report.

Two Major, Disruptive Changes Coming to Labs Read More »

Anthem Seeks $13.5M from California Hospital

Laboratory Billing / Joseph Burns

CEO SUMMARY: Anthem charged 37-bed Sonoma West Medical Center in Sebastopol, Calif., of engaging in an improper billing scheme to defraud Anthem and its affiliated Blue Cross and Blue Shield plans. In effect, the charge is a notification to SWMC that Anthem intends to sue SWMC and its owner if it does not recover the $13.5 million in a timely

To access this post, you must purchase The Dark Report.

Anthem Seeks $13.5M from California Hospital Read More »

;